Loading…
Sectoral / Thematic · quant Mutual Fund · AMFI code 151853quant Healthcare Fund
Disclosed for 38 months, Aug 2023 to Sep 2026.
Portfolio value
₹160 Cr
up ₹22.9 Cr vs Aug 2023
- Stocks held
- 17
- up 3 vs Aug 2023
- Top 10 weight
- 76.9%
- of the portfolio in its ten largest
- Largest position
- 10.0%
- Aurobindo Pharma Limited 26/10/2023
- Cash & debt
- 0.5%
- cash, money market and debt
- Moves this month
- 5 in · 2 out
- added to 8, trimmed 3
quant Healthcare Fund is an active equity fund in the Sectoral / Thematic category from quant Mutual Fund. In September 2023 it disclosed 17 stocks worth ₹160 Cr, up ₹22.9 Cr from Aug 2023. Its largest positions were Aurobindo Pharma Limited 26/10/2023 (10.0%), Reliance Industries Limited (9.4%), Sun Pharmaceutical Industries Limited (8.7%); the ten largest together made up 76.9% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 50.1% of its equity. Cash and debt stood at 0.5%. Compared with Aug 2023 the fund entered 5 new stocks and exited 2.
Against 229 other Sectoral / Thematic funds
Concentration
97%
Top-10 weight is higher than 97% of peers
Breadth
4%
Holds more stocks than 4% of peers
Cash
7%
Holds more cash than 7% of peers
What these mean: concentration · cash
Holdings in September 2023
Download CSVEvery line the fund disclosed, with the change against Aug 2023. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Aurobindo Pharma Limited 26/10/2023 Derivative | 9.98% | up 9.98 pts | ₹16 Cr | up ₹16 Cr | New |
| Reliance Industries Limited | 9.36% | up 1.13 pts | ₹15 Cr | up ₹3.7 Cr | Added |
| Sun Pharmaceutical Industries Limited | 8.71% | up 1.51 pts | ₹14 Cr | up ₹4.1 Cr | Added |
| Poly Medicure Limited | 8.66% | down 1.31 pts | ₹13.9 Cr | up ₹18 L | Added |
| Aster DM Healthcare Limited | 8.18% | down 0.27 pts | ₹13.1 Cr | up ₹1.5 Cr | Added |
| Indoco Remedies Limited | 6.77% | up 6.77 pts | ₹10.9 Cr | up ₹10.9 Cr | New |
| Piramal Pharma Limited | 6.56% | down 1.13 pts | ₹10.5 Cr | down ₹5 L | Held |
| IPCA Laboratories Limited | 6.42% | down 0.57 pts | ₹10.3 Cr | up ₹68 L | Added |
| 91 Days Tbill (MD Debt | 6.22% | down 1.00 pts | ₹10 Cr | up ₹5 L | Added |
| Fortis Healthcare Limited | 6.04% | down 0.84 pts | ₹9.7 Cr | up ₹24 L | Added |
| GlaxoSmithKline Pharmaceuticals Limited | 5.02% | up 2.94 pts | ₹8.1 Cr | up ₹5.2 Cr | Added |
| Sequent Scientific Limited | 3.58% | up 3.58 pts | ₹5.7 Cr | up ₹5.7 Cr | New |
| AstraZeneca Pharma India Limited | 3.27% | down 0.34 pts | ₹5.2 Cr | up ₹28 L | Added |
| Granules India Limited | 3.10% | up 3.10 pts | ₹5 Cr | up ₹5 Cr | New |
| Apollo Hospitals Enterprise Limited | 2.80% | up 2.80 pts | ₹4.5 Cr | up ₹4.5 Cr | New |
| Adani Ports & Special Economic Zone Ltd 26/10/2023 Derivative | 2.69% | up 2.69 pts | ₹4.3 Cr | up ₹4.3 Cr | New |
| Gufic Biosciences Limited | 2.27% | down 0.66 pts | ₹3.6 Cr | down ₹39 L | Trimmed |
| BROOKS Laboratories Limited | 2.02% | down 0.53 pts | ₹3.2 Cr | down ₹26 L | Trimmed |
| Aarti Drugs Limited | 1.62% | up 1.62 pts | ₹2.6 Cr | up ₹2.6 Cr | New |
| Kopran Limited | 1.43% | down 0.32 pts | ₹2.3 Cr | down ₹12 L | Trimmed |
| Sun Pharmaceutical Industries Limited 26/10/2023 Derivative | 1.02% | up 1.02 pts | ₹1.6 Cr | up ₹1.6 Cr | New |
| Cash, TREPS & receivables | −5.72% | down 1.63 pts | −₹9.2 Cr | down ₹3.5 Cr | Trimmed |
What changed, Aug 2023 to Sep 2023
New New positions (5)
- Indoco Remedies Limited6.8% · ₹10.9 Cr
- Sequent Scientific Limited3.6% · ₹5.7 Cr
- Granules India Limited3.1% · ₹5 Cr
- Apollo Hospitals Enterprise Limited2.8% · ₹4.5 Cr
- Aarti Drugs Limited1.6% · ₹2.6 Cr
Exited Exited (2)
- Suven Pharmaceuticals Limitedwas 6.7% · ₹9.2 Cr
- Jio Financial Services Limitedwas 5.2% · ₹7.1 Cr
Added Biggest additions
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Aug 2023, the weight rose most in Pharmaceuticals (+8.1 pts) and Healthcare Services (+0.6 pts), and fell most in Finance (−6.7 pts) and Healthcare Equipment & Supplies (−2.5 pts).
- Pharmaceuticals0.0% → 8.1%new+8.1 pts
- Healthcare Services19.7% → 20.3%+0.6 pts
- Petroleum Products10.6% → 11.2%+0.6 pts
- Finance6.7% → 0.0%exited−6.7 pts
- Healthcare Equipment & Supplies12.8% → 10.3%−2.5 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Aug 2023 | Sep 2023 |
|---|---|---|
| Pharmaceuticals & Biotechnology | 50.2% | 50.1% |
| Healthcare Services | 19.7% | 20.3% |
| Petroleum Products | 10.6% | 11.2% |
| Healthcare Equipment & Supplies | 12.8% | 10.3% |
| Pharmaceuticals | — | 8.1% |
Allocation in Sep 2023change vs Aug 2023
- Pharmaceuticals & Biotechnology (10)50.1%▼ 0.1 pts
- Healthcare Services (3)20.3%▲ 0.6 pts
- Petroleum Products (1)11.2%▲ 0.6 pts
- Healthcare Equipment & Supplies (1)10.3%▼ 2.5 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Sep 2023
0.5%
▼ 2.6 pts vs Aug 2023
- Cash alone
- −5.7%
- cash and net receivables
- A year earlier
- —
- no disclosure
- Last 12 months
- 0.5% – 3.1%
- lowest to highest · record 3.1% in Aug 2023
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.